If you have a media enquiry or further questions regarding public relation activities at AiCuris please contact here:

 


 

01.02.2021

AiCuris changes its legal form: AiCuris Anti-infective Cures GmbH becomes AiCuris AG

Transition will support the Company in exploring additional opportunities for future growth

more ...

13.01.2021

AiCuris selects three novel anti-infective treatment approaches as winners of the AiCubator Resident Status, a corporate innovative accelerator initiative

AiCuris selects three novel anti-infective treatment approaches as winners of the AiCubator Resident Status, a corporate innovative accelerator initiative

more ...

08.01.2021

AiCuris to Present at the 39th Annual J.P. Morgan Healthcare Conference

AiCuris to Present at the 39th Annual J.P. Morgan Healthcare Conference

more ...